Family offices made 55 direct investments in companies in April 2026, up from 39 in March.
Nearly one-third of April's investments were in healthcare and life sciences companies.
April Sees Surge in Family Office Deals
After a marked slowdown in March—attributed to the outbreak of the Iran war—family office direct investments rebounded sharply in April. According to data provided exclusively to CNBC by Fintrx, a private wealth intelligence platform, family offices completed 55 direct investments in companies last month.
Spotlight on Healthcare and AI
Nearly one-third of all April investments targeted healthcare and life sciences firms, signaling strong confidence in the sector.
Key Deals of the Month
Laurene Powell Jobs' Emerson Collective was particularly active, participating in seed and Series A rounds for two cutting-edge companies:
- Ultralight, an AI software platform for personalized healthcare, raised $9.3 million in seed funding from Emerson Collective and other investors.
- Stipple Bio, a developer of targeted cancer therapies, raised $100 million in a Series A round co-led by Andreessen Horowitz.
"Nearly one-third of April's investments were in healthcare and life sciences companies."